ru24.pro
News in English
Июль
2024

BioNTech, Regeneron rack up response rate win for mRNA cancer candidate in phase 2 trial

0
BioNTech, Regeneron rack up response rate win for mRNA cancer candidate in phase 2 trial ntaylor